Olux: profile and news

Connetics Reports Preliminary Results for First Quarter 2006 ...  May 3, 2006
Total revenues for the first quarter of 2006 were $47.7 million, including Soriatane(R) sales of $19.0 million, OLUX(R) sales of $14.1 million, Evoclin(R ... - PharmaLive.com (press release),

Connetics Names Sunil Patel Vice President, Corporate Development ...  May 9, 2006
Connetics has branded its proprietary foam drug delivery vehicle VersaFoam(R). The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05 ... - PharmaLive.com (press release),